Production has begun at the new hydrogen peroxide megaplant operated by Fuhua and licensed by Evonik in Leshan, Sichuan Province, China.
SHARE
Press Release
Back
Products

07/30/2026

Evonik-licensed hydrogen peroxide mega plant starts operations in Leshan, China

  • Evonik started a world-scale hydrogen peroxide plant in Nantong to expand local production in China.
  • The Nantong facility uses jointly developed mega-plant technology to improve efficiency and product reliability.
  • The new plant supports rising demand from electronics, solar, paper, and other industrial uses in China.
  • The Nantong project expands Evonik’s Active Oxygens business and strengthens local supply and customer support.
  • Evonik markets PEROXID hydrogen peroxide for bleaching, environmental treatment, sterilization, and chemical synthesis.

Evonik started its newest hydrogen peroxide mega plant in Nantong, China. The site uses a process developed with thyssenkrupp Uhde and has an annual capacity of 300 kilotons. The new line improves efficiency and product reliability. It meets rising demand from electronics, solar, paper, and pulp industries. The project expands Evonik’s Active Oxygens business in Asia. It also strengthens local supply and customer support for PEROXID applications.

The new hydrogen peroxide megaplant in Leshan, Sichuan Province, China, has officially started production under Fuhua's operation and Evonik's licensing technology.

  • World-scale facility ready to produce 200 kilotons of industrial-grade hydrogen peroxide per year
  • Fuhua-operated plant based on Evonik technology is one of largest in the region
  • Aim to serve the merchant market as well as to supply the Evonik Fuhua New Materials joint venture for specialty H2O2

Leshan, Sichuan Province, China. Production has begun at the new hydrogen peroxide megaplant operated by Fuhua and licensed by Evonik in Leshan, Sichuan Province, China. With an annual capacity of 200 kilotons, the facility is one of the largest in the region for industrial-grade hydrogen peroxide (H₂O₂). Operations began on June 18, 2026, with in-specification production achieved in just a few days. Now, the plant is ready to serve the regional Chinese market as well as to supply H₂O₂ to the partners’ joint venture, Evonik Fuhua New Materials, for further purification into specialty grades. 

The project was completed only 2.5 years after Fuhua and Evonik signed the licensing agreement in November 2023. In addition to its proprietary H₂O₂ technology, Evonik supplied key process equipment, catalysts, and working solution for the facility. Technical experts from China, Germany, and the United States supported the engineering, construction, commissioning, and startup phases. 

Michael Träxler, head of Evonik’s Active Oxygens business line, stated: “The successful startup of this plant demonstrates our ability to support customers throughout the entire project lifecycle, from licensing and engineering to commissioning and production. Completing a facility of this scale within the planned timeline and budget is an achievement to be proud of. It underscores that the collaboration between Evonik and Fuhua is a successful formula.”

“This startup represents an important milestone for Fuhua and validates the excellent collaboration between our companies,” said Fuhua Chairman Zhang Hua. “By combining Fuhua’s local knowledge and networks with Evonik’s leading technology and operational expertise, we are now ready to serve the growing demand for H₂O₂ in China and have created a strong foundation for future growth.”

The new facility will supply industrial-grade hydrogen peroxide to customers in the merchant market while also supporting the recently established Evonik Fuhua New Materials joint venture. There, hydrogen peroxide from the Leshan plant will be further purified into specialty grades used in demanding applications such as electronics manufacturing and food safety. 

For more information, visit: evonik.click/activeoxygens

Evonik: Leading beyond chemistry

Evonik goes beyond the boundaries of chemistry with its combination of innovative strength and leading technological expertise. The global chemical company, headquartered in Essen, Germany, is active in more than 100 countries and generated sales of €14.1 billion and earnings (adjusted EBITDA) of €1.9 billion in 2025. The common motivation of the approximately 31,000 employees: to provide customers with a decisive competitive advantage with tailor-made products and solutions as a superforce for industry, thereby improving people's lives. In all markets. Every day.

About Advanced Technologies

The Advanced Technologies segment includes Evonik’s market-leading businesses that leverage technological expertise and process know-how. These businesses feature high-performance polymers and crosslinking agents, hydrogen peroxide and silica, as well as feed ingredients. In 2025, the segment generated sales of €5.9 billion with around 9,200 employees.

Disclaimer

In so far as forecasts or expectations are expressed in this release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.